The United States

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialized oncology CRO division

George Clinical In The United States of America

George Clinical, the leading Asia-Pacific CRO, expands into the USA with an acquisition of a specialized oncology CRO.

Headquartered in Sydney, Australia, George Clinical has offices in China, India, Hong Kong, South Korea, Taiwan, Malaysia, New Zealand, United Kingdom, and now multiple offices in the USA.
Over the years, George Clinical has grown rapidly across the Asia-Pacific region and is continuing to develop its global operations. The combination of a strong commercial proficiency and clinical research and scientific excellence positions George Clinical as a high quality, global CRO with substantial clinical and scientific assets.

George Clinical’s operations now expand further in the USA, with 66 new people and leaders specializing in oncology trials coupled with the existing team create an full capabilities offering. We are here to support our USA customers with their clinical trial and scientific consultation needs and to lead oncology trials across our core operational facilities in the Asia-Pacific region.

Our People in The United States are Experienced in

Cardiovascular 49%

Central Nervous System 57%

Medical Devices 38%

Endocrinology 44%

Oncology 95%

Respiratory 36%

Nephrology 33%

Contact

Memphis
6555 Quince, Suite 503
Memphis, TN 38119 USA

Kansas City
Building 12, Suite 200
10975 Benson Dr
Overland Park, KS 66210 USA
Phone: +1-901-259-0888

Details

Population 321 million
Number of Personnel 66
Official Language English 79.2%, Spanish 12.9%, other Indo-European 3.8%, Asian and Pacific island 3.3%, other 0.9%
Hospital Records Language English
In-country services Business Development
Scientific Leadership
Oncology specialists
Project Management
Clinical Operations
Clinical Compliance
Regulatory Services
Medical and Safety management
Data Management
Statistics
Health Economics
GDP – per capita (US $) $55,800
Health Expenditures 17.1% of GDP

Join our Mailing List


Add George Clinical to your network